Literature DB >> 20443646

Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Teri R Thomsen1, Robert L Rodnitzky.   

Abstract

Juvenile parkinsonism, with onset prior to age 21 years, is a relatively rare syndrome. It is caused by a group of heterogeneous entities that can present with a clinical picture similar to idiopathic Parkinson's disease or manifest parkinsonism as part of a spectrum of other signs. Diagnostic testing is guided by the presenting symptoms and aimed at uncovering potentially reversible and/or treatable causes. If an underlying condition is found, treatment is tailored accordingly. Otherwise, treatment is symptomatic and relies on medications commonly employed to treat idiopathic Parkinson's disease. Juvenile parkinsonism patients tend to be plagued by treatment-induced complications, so caution must be employed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20443646     DOI: 10.2165/11533130-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  89 in total

1.  Phenomenology of "Lubag" or X-linked dystonia-parkinsonism.

Authors:  Virgilio Gerald H Evidente; Joel Advincula; Raymund Esteban; Paul Pasco; Jhoe Anthony Alfon; Filipinas F Natividad; Joven Cuanang; Amado San Luis; Katrina Gwinn-Hardy; John Hardy; Dena Hernandez; Andrew Singleton
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  New pathologic observations in juvenile onset parkinsonism with dystonia.

Authors:  W R Gibb; H Narabayashi; M Yokochi; R Iizuka; A J Lees
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 3.  An update on the treatment of Parkinson's disease.

Authors:  Joseph Jankovic
Journal:  Mt Sinai J Med       Date:  2006-07

4.  Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.

Authors:  A Schrag; Y Ben-Shlomo; R Brown; C D Marsden; N Quinn
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

Review 5.  The treatment of movement disorders by deep brain stimulation.

Authors:  Hong Yu; Joseph S Neimat
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

6.  Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene.

Authors:  Marianna Capecci; Luca Passamonti; Ferdinanda Annesi; Grazia Annesi; Michele Bellesi; Innocenza Claudia Cirò Candiano; Riccardo Ricciuti; Maurizio Iacoangeli; Massimo Scerrati; Mario Zappia; Patrizia Tarantino; Elvira Valeria De Marco; Donatella Civitelli; Sara Carrideo; Leandro Provinciali; Maria Gabriella Ceravolo; Aldo Quattrone
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

Review 7.  HIV-related movement disorders: epidemiology, pathogenesis and management.

Authors:  Francisco Cardoso
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

8.  Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease.

Authors:  Laura Cif; Brigitte Biolsi; Sophie Gavarini; Aude Saux; Santiago Gil Robles; Cornel Tancu; Xavier Vasques; Philippe Coubes
Journal:  Mov Disord       Date:  2007-10-31       Impact factor: 10.338

9.  Levodopa therapy in a Lesch-Nyhan disease patient: pathological, biochemical, neuroimaging, and therapeutic remarks.

Authors:  Mercedes Serrano; Belen Pérez-Dueñas; Aida Ormazábal; Rafael Artuch; Jaume Campistol; Rosa J Torres; Angels García-Cazorla
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

10.  Factors associated with HD CAG repeat instability in Huntington disease.

Authors:  V C Wheeler; F Persichetti; S M McNeil; J S Mysore; S S Mysore; M E MacDonald; R H Myers; J F Gusella; N S Wexler
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

View more
  3 in total

1.  DBS in pediatric patients: institutional experience.

Authors:  Huseyin Canaz; Isik Karalok; Baris Topcular; Mert Agaoglu; Zuhal Yapici; Sabri Aydin
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

Review 2.  Pediatric indications for deep brain stimulation.

Authors:  Matthew F DiFrancesco; Casey H Halpern; Howard H Hurtig; Gordon H Baltuch; Gregory G Heuer
Journal:  Childs Nerv Syst       Date:  2012-07-25       Impact factor: 1.475

3.  Juvenile Parkinson Disease.

Authors:  Arsalan Anwar; Sidra Saleem; Aisha Akhtar; Sara Ashraf; Mirza Fawad Ahmed
Journal:  Cureus       Date:  2019-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.